1. Home
  2. MSEX vs COLL Comparison

MSEX vs COLL Comparison

Compare MSEX & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSEX
  • COLL
  • Stock Information
  • Founded
  • MSEX 1897
  • COLL 2002
  • Country
  • MSEX United States
  • COLL United States
  • Employees
  • MSEX N/A
  • COLL N/A
  • Industry
  • MSEX Water Supply
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • MSEX Utilities
  • COLL Health Care
  • Exchange
  • MSEX Nasdaq
  • COLL Nasdaq
  • Market Cap
  • MSEX 895.1M
  • COLL 910.2M
  • IPO Year
  • MSEX N/A
  • COLL 2015
  • Fundamental
  • Price
  • MSEX $63.87
  • COLL $30.00
  • Analyst Decision
  • MSEX Hold
  • COLL Strong Buy
  • Analyst Count
  • MSEX 3
  • COLL 5
  • Target Price
  • MSEX $59.33
  • COLL $43.60
  • AVG Volume (30 Days)
  • MSEX 251.2K
  • COLL 444.8K
  • Earning Date
  • MSEX 05-07-2025
  • COLL 05-08-2025
  • Dividend Yield
  • MSEX 2.13%
  • COLL N/A
  • EPS Growth
  • MSEX 39.94
  • COLL 43.56
  • EPS
  • MSEX 2.47
  • COLL 1.86
  • Revenue
  • MSEX $191,877,000.00
  • COLL $631,449,000.00
  • Revenue This Year
  • MSEX $10.20
  • COLL $20.00
  • Revenue Next Year
  • MSEX $6.56
  • COLL $3.93
  • P/E Ratio
  • MSEX $25.88
  • COLL $16.09
  • Revenue Growth
  • MSEX 15.40
  • COLL 11.41
  • 52 Week Low
  • MSEX $45.42
  • COLL $27.28
  • 52 Week High
  • MSEX $70.73
  • COLL $42.29
  • Technical
  • Relative Strength Index (RSI)
  • MSEX 67.03
  • COLL 51.96
  • Support Level
  • MSEX $59.07
  • COLL $29.01
  • Resistance Level
  • MSEX $64.97
  • COLL $30.53
  • Average True Range (ATR)
  • MSEX 1.60
  • COLL 0.89
  • MACD
  • MSEX 0.03
  • COLL 0.04
  • Stochastic Oscillator
  • MSEX 81.36
  • COLL 62.91

About MSEX Middlesex Water Company

Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The firm primarily operates in the eastern states of New Jersey, Delaware, and Pennsylvania. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: